What is the recommended PCAB (Proton pump inhibitor (PPI), Clarithromycin, Amoxicillin) regimen for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PCAB Regimen for H. pylori Eradication

Use clarithromycin triple therapy (PPI + clarithromycin + amoxicillin) for 14 days ONLY if your local clarithromycin resistance is documented to be less than 15% and local eradication rates exceed 90%; otherwise, choose bismuth quadruple therapy as first-line treatment. 1

Regimen Components

When Clarithromycin Triple Therapy is Appropriate:

  • Esomeprazole 40 mg twice daily (preferred high-potency PPI) 1
  • Amoxicillin 1000 mg twice daily 1, 2
  • Clarithromycin 500 mg twice daily 1
  • Duration: 14 days 1

Critical Geographic Restriction:

This regimen is classified as "effective only when susceptibility based" and should NOT be used empirically unless your region has documented clarithromycin resistance <15% and achieves >90% local cure rates. 1 In most regions worldwide, standard triple therapy now provides unacceptably low treatment success. 3

Administration Timing

  • Esomeprazole: Take 30 minutes before meals on an empty stomach 1
  • Amoxicillin: Take at the start of a meal or 30 minutes after meals 1, 2
  • Clarithromycin: Take with other medications twice daily 1

Alternative First-Line Therapy (Preferred in Most Regions)

If clarithromycin resistance is ≥15% or unknown, use bismuth quadruple therapy instead: 1

  • Bismuth subsalicylate ~300 mg four times daily 4
  • Metronidazole 500 mg three times daily 4
  • Tetracycline 500 mg four times daily 4
  • PPI (standard dose) twice daily 4
  • Duration: 14 days 4

Evidence Quality and Nuances

The American Gastroenterological Association and American College of Gastroenterology guidelines emphasize that clarithromycin triple therapy has become ineffective in most populations due to rising resistance. 1 Research from 2010 confirms that this regimen "now provides unacceptably low treatment success" with few exceptions globally. 3

High-quality evidence from 2013 shows that using high-dose PPI (lansoprazole 60 mg twice daily) with long-acting clarithromycin can achieve 100% eradication in low-resistance areas, regardless of CYP2C19 genotype. 5 However, this requires documented low clarithromycin resistance.

A 2020 meta-analysis found that metronidazole-based triple therapy (PAM) showed comparable or superior efficacy to clarithromycin-based therapy (PAC), particularly in patients over 60 years old and in recent years. 6

Common Pitfalls to Avoid

  • Never use clarithromycin triple therapy empirically without knowing local resistance patterns 1
  • Do not use 7-day regimens; 14 days is mandatory for optimal eradication 1
  • Avoid pantoprazole; prefer esomeprazole 40 mg or rabeprazole 20-40 mg twice daily 4
  • After any prior treatment failure, susceptibility testing is mandatory before using this regimen 1
  • Complete adherence to the full 14-day course is essential for success 4

Dosing in Special Populations

For patients with severe renal impairment (GFR <30 mL/min), amoxicillin dosing must be adjusted to 500 mg every 12 hours (GFR 10-30 mL/min) or 500 mg every 24 hours (GFR <10 mL/min). 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.